Abstract:Objective To prepare cisplatin polybutylcyanoacrylate stleath nanoparticle(CDDP-PBCA-mPEG)and observe the different tissue distributions of the nanoparticles in the mice body after the injection via lateral tail vein,and to study the targeting distribution of CDDP-PBCA-mPEG on normal mice livers.Methods CDDP-PBCA-mPEG was prepared by double emulsion method,with the surfacemodified by methoxypolyethyleneglycol.High-performance liquid chromatography(HPLC) method was established using methyl alcohol andwater(55:45) as mobile phase;detection was done at 210nm.Sixty mice were randomly divided into 2 groups with 30 mice in each group:non conjugated free CDDP group and CDDP-PBCA-mPEG group,A single dose of either conjugated or free cisplatin equaled 5mg / kg of body weight was delivered via the tail vein.Five mice in eachtrail were sacrificed at 15,30 minutes,1,2,6 and 12 hours after the injection,respectively.The cisplatin concentrations in the collected livers,kidneys,spleens,hearts,lungs and plasma were demonstrated using a high performance liquid chromatography with fluorescence detector.Results The mean diameter of the prepared CDDP-PBCA-mPEG was 170.9 nm;the mean entrapment efficiency of the particles was 60.1%;and the drug loading rate was 3.88%.The cisplatin concentrations of the mice liver in the experimental groups was significantly higher than those in the control groups(P 0.01).The nanoparticle conjugated cisplatin was significantly lower than those in the control groups(P 0.01) and cleaned up quickly from the kidney tissues.Cisplatin was released slowly in the liver and plasma during the detection period in the experimental groups.Conclusion CDDP-PBCA-mPEG has the liver targeting with slow medicine release.It also decreases the medicine distribution in the kidney and other organs.In the treatment of liver cancer,the polybutylcyanoacrylate stleath nanoparticle system has a good liver targeting ability,which increases the anticancer activity and markedly decreases the toxicity of cisplatin.

Long Circulating Anionic Liposomes for Hepatic Targeted Delivery of Cisplatin

Cholesterol-based Anionic Long-Circulating Cisplatin Liposomes with Reduced Renal Toxicity.

LHRH-peptide Conjugated Dextran Nanoparticles for Targeted Delivery of Cisplatin to Breast Cancer.

Anionic Long Circulating Liposomes for Hepatic Targeted Delivery of Cisplatin

Developing a Highly Stable PLGA-mPEG Nanoparticle Loaded with Cisplatin for Chemotherapy of Ovarian Cancer.

Ph Responsible and Fluorescent Cy5.5-PEG-g-A-HA/CDDP Complex Nanoparticles: Synthesis, Characterization, and Application for Targeted Drug Delivery

A Poly(γ, L-glutamic Acid)-Citric Acid Based Nanoconjugate for Cisplatin Delivery.

Estrone-targeted PEGylated Liposomal Nanoparticles for Cisplatin (DDP) Delivery in Cervical Cancer

Complex of Cisplatin with Biocompatible Poly(Ethylene Glycol) with Pendant Carboxyl Groups for the Effective Treatment of Liver Cancer

Methoxypoly(ethylene glycol)-block-poly(L-glutamic acid)-loaded cisplatin and a combination with iRGD for the treatment of non-small-cell lung cancers.

Cisplatin-loaded polymeric nanoparticles: characterization and potential exploitation for the treatment of non-small cell lung carcinoma.

Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation.

Anticancer effect of long-circulating nanometer liposome packaging cisplatin in vitro and in vivo

Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.

Tumoral Acidic Ph-Responsive Cis-Diaminodichloroplatinum-incorporated Cy5.5-PEG-g-A-HA Nanoparticles for Targeting Delivery of CDDP Against Cervical Cancer

Coordination self-assembly of platinum-bisphosphonate polymer-metal complex nanoparticles for cisplatin delivery and effective cancer therapy.

Lipid-Coated Cisplatin Nanoparticles Induce Neighboring Effect and Exhibit Enhanced Anticancer Efficacy

Study on Targeting Distribution of Cisplatin Stealth Nanoparticles in Normal Mice

A Cross-Linked Polymeric Micellar Delivery System for Cisplatin(iv) Complex

Studies on the Poly(lactic-Co-glycolic) Acid Microspheres of Cisplatin for Lung-Targeting.

Coordinative Double Hydrophilic All-Polyether Micelles for pH-Responsive Delivery of Cisplatin